Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.

Area of Science:

• Immunology
• Neuroimmunology
• Cellular Biology

Background:

• Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Progressive forms of MS, including Primary Progressive MS (PPMS) and Secondary Progressive MS (SPMS), are characterized by continuous neurological decline.
• Natural Killer (NK) cells are lymphocytes crucial for innate immunity, with distinct subsets implicated in various immune responses.

Purpose of the Study:

• To investigate the percentages of specific Natural Killer (NK) cell subpopulations in the peripheral blood of patients with untreated progressive multiple sclerosis (MS).
• To compare NK cell profiles in patients with Primary Progressive MS (PPMS) and Secondary Progressive MS (SPMS) against age and sex-matched healthy controls.
• To explore the potential involvement of specific NK cell subsets in the pathogenesis of progressive MS.

Main Methods:

• Flow cytometry was utilized to quantify distinct NK cell subsets.
• Peripheral blood samples were collected from untreated PPMS patients, SPMS patients, and healthy subjects.
• Analysis focused on percentages of CD3(-)CD56(bright), CD3(-)CD56(dim), CD3(-)CD56(bright)perforin(+), and CD3(-)CD56(dim)perforin(+) NK cells.

Main Results:

• Both PPMS and SPMS patients demonstrated significantly increased percentages of circulating CD3(-)CD56(dim)perforin(+) NK cells compared to healthy controls.
• No significant differences were observed in other evaluated NK cell subsets between patient groups and controls.
• The data indicates a specific expansion of perforin-expressing CD56(dim) NK cells in progressive MS.

Conclusions:

• The elevated presence of CD3(-)CD56(dim)perforin(+) NK cells in progressive MS patients suggests a potential role for this specific NK cell subpopulation in disease pathogenesis.
• These findings warrant further investigation into the functional capabilities and specific contributions of CD56(dim)perforin(+) NK cells in the context of MS.
• Targeting or understanding this NK cell subset may offer new therapeutic avenues for managing progressive forms of MS.